Gene Therapy Approaches to Replace or Restore Dystrophin PF-06939926 – Kasia Lobello, MD (Pfizer, Inc.) RGX-202 – Jahannaz Dastgir, DO (REGENXBIO) scAAV9.U7-ACCA – Kevin Flanigan, MD (Nationwide Children’s Hospital) SGT-001 – Carl Morris, PhD (Solid Biosciences) SRP-9001 – Teji Singh, MD (Sarepta Therapeutics) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 53:34 In the Pipeline: Dystrophin Restoration 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 54:53 In the Pipeline: Protecting the Muscle (PPMD’s 2021 Virtual Annual Conference) 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 49:53 In the Pipeline: Gene Editing 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 58:55 In the Pipeline: Gene Therapy 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 51:09 In the Pipeline: Reducing Inflammation 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 55:32 In the Pipeline: Improving the Heart and Mitochondria 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 1:10:27 In the Pipeline: Pre-Clinical Gene Therapy 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings 47:59 In the Pipeline: Next-Gen Exon Skipping 3 years ago 2021 PPMD Virtual Conference: Live Sessions,Conferences & Meetings «1…1112131415…25»Page 13 of 25